TB-500

TB-500 is a synthetic version of the naturally occurring 43-amino acid peptide Thymosin Beta-4 (Tβ4), which is found in virtually all human and animal cells. Thymosin Beta-4 plays a fundamental role in cellular processes including actin polymerization, cell migration, and differentiation. As the primary intracellular G-actin sequestering peptide, it regulates actin dynamics that are critical for cell motility, organogenesis, and tissue repair. Research interest in TB-500 centers on its ability to promote wound healing, reduce inflammation, and modulate tissue remodeling.

Preclinical studies have demonstrated that Thymosin Beta-4 promotes dermal and corneal wound healing, cardiac repair following myocardial infarction, and recovery from central nervous system injuries. The peptide upregulates the expression of laminin-5, a key component of the extracellular matrix, and promotes the migration of endothelial cells and keratinocytes to wound sites. In cardiac research, Tβ4 has been shown to activate epicardium-derived progenitor cells and to reduce infarct size when administered following ischemic injury in murine models.

Additional research has explored TB-500's anti-inflammatory properties. The peptide has been reported to downregulate pro-inflammatory cytokines and to modulate NF-κB signaling pathways. Studies in equine models have investigated its effects on tendon and ligament recovery, while ophthalmic research has examined its potential for accelerating corneal epithelial healing. These findings suggest a multifaceted mechanism of action that extends beyond simple tissue repair.